Study reveals why many opt out of multiplex testing for cancer-related gene variants
the ONA take:
Many patients do not want the information that comprehensive genetic testing provides, according to a study from researchers at the Perelman School of Medicine at the University of Pennsylvania and the Basser Center for BRCA in Penn’s Abramson Cancer Center.
In the study, 49 patient participants with a family or personal history that increased their risk for developing breast and other forms of cancer were offered multiplex testing. More than one-third of the participants declined the test because of uncertainty of the results.
Multiplex testing allows for simultaneous analysis of alterations in multiple cancer-related genes, whereas targeted testing focuses on a specific genetic mutations (eg, BRCA1 and BRCA2 gene mutations). However, the significance of alterations in many of the genes analyzed in multiplex testing is unknown.
All 49 participants received counseling on the advantages and disadvantages of the tests. After counseling, 16 participants declined multiplex testing or being told their results.
Of the remaining participants, 16 tested negative for any cancer-related variants, five tested positive, and 12 were found to have gene variants of uncertain significance (meaning that whether the changes are benign or tied to cancers is unclear).
Many patients do not want the information that comprehensive genetic testing provides.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- Screening Recommendations for Children with Common Cancer Predisposition Syndromes
- Significance of Prostate Cancer Treatment-Related Factors Differ in Black, White Men
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Lack of Transfusion Services a Barrier to Hospice Care for Patients With Blood Cancers
- Aspirin Use May Lower Breast Cancer Risk in Women with Diabetes
- Ethnic Differences, Cultural Barriers Negatively Impact Mammography Follow-up Among Asian Ethnic Groups
- Study Questions Safety of E-cigarettes vs Regular Tobacco Cigarettes
- Changes in Pulmonary Function Tests in Breast Carcinoma Patients Treated With Locoregional Post-mastectomy Radiotherapy: Results of a Pilot Study
- Increases in Liver Cancer Incidence Influenced by Higher Rates of Comorbidities
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|